| ￥5800 | |
| Z04675-100 | |
|
|
|
|
|
|
|
|
|
| Species | Mouse | ||||
| Protein Construction |
|
||||
| Conjugate | Biotin | ||||
| Purity | > 95% as determined by BisTris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Mouse PDL1, His Tag captured on CM5 Chip via antihis antibody can bind PD-1/PDCD1 hFc Chimera[Biotin], Mouse in SPR assay (Biacore T200). Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 42.9 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 60-70 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
The purity of PD-1/PDCD1 hFc Chimera[Biotin], Mouse is greater than 95% as determined by SEC-HPLC. »
PD-1/PDCD1 hFc Chimera[Biotin], Mouse on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Mouse PD-L1, His Tag captured on CM5 Chip via anti-his antibody can bind PD-1/PDCD1 hFc Chimera[Biotin], Mouse, hFc Tag with an affinity constant of 3.35 μM as determined in SPR assay (Biacore T200). »
| Target Background | Programmed cell death protein 1, also known as PD-1 and CD279 , is a protein found on the surface of cells that has a role in regulating the immune system's response to the cells of the human body by down-regulating the immune system and promoting self tolerance by suppressing T cell inflammatory activity. |
| Synonyms | PDCD1; PD1; CD279; SLEB2; PD-1 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
